TREATMENT OF CANDIDA-ALBICANS MANNAN-SPECIFIC DOWNREGULATORY CELL-POPULATIONS WITH DIVERGENT CONCENTRATIONS OF MONOPHOSPHORYL LIPID-A AND INTACT LIPOPOLYSACCHARIDE IN-VITRO ABROGATES THEIR EFFECT ON DELAYED-HYPERSENSITIVITY
Je. Domer et al., TREATMENT OF CANDIDA-ALBICANS MANNAN-SPECIFIC DOWNREGULATORY CELL-POPULATIONS WITH DIVERGENT CONCENTRATIONS OF MONOPHOSPHORYL LIPID-A AND INTACT LIPOPOLYSACCHARIDE IN-VITRO ABROGATES THEIR EFFECT ON DELAYED-HYPERSENSITIVITY, Cellular immunology, 167(1), 1996, pp. 8-17
We have shown previously that splenocytes from mice injected with Cand
ida albicans mannan (MAN) suppress MAN-specific delayed hypersensitivi
ty (DH) when transferred to immunized recipients and that treatment of
donor mice with monophosphoryl lipid A (MLA) derived from Salmonella
typhimurium or Salmonella minnesota shortly before transfer abrogated
the downregulatory activity. me now show that treatment of splenocytes
in vitro at 4 degrees C with 5 ng/ml MLA or 0.05 ng/ml S. typhimurium
lipopolysaccharide (LPS) for 30 min before transfer also abrogated do
wnregulatory activity. Higher or lower doses of MLA, 5 mu g or 5 pg, a
ppeared to increase the suppressor activity slightly (5 mu g) or had n
o effect (5 pg). LPS induced similar effects but the concentrations of
LPS required to show the effects were 100-fold less than those of MLA
. The effect of MLA appeared to be on cents) in the transfer populatio
n involved in MAN-specific DH, in that spleen cells from normal mice t
reated with MLA prior to transfer had no effect on DH. Finally, the po
pulation of MLA-responsive cells mediating downregulation could not be
concentrated on MLA-coated plates, suggesting that the MAN-specific d
ownregulatory cell(s) either did not bind to MLA or did not bind to ML
A with sufficient avidity to remain attached during the washing proced
ures, The feasibility of abrogating suppression by treatment of lympho
id cells in vitro will allow a more detailed analysis of the mechanism
Of abrogation. (C) 1996 Academic Press,Inc.